Sequential usage of imidazole followed by tamoxifen to enhance the anticancer effect of tamoxifen in estrogen receptor-positive breast cancer cell lines.

被引：2
|
作者：
Inci, Tarik
Kahraman, Erkan
Goker, Erdem
机构：
[1] Ege Univ Hosp, Izmir, Turkey
[2] Ege Univ, Ataturk Hlth Care Vocat Sch, Izmir, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e15057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15057
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer - Response
    Dignam, J
    Fisher, B
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (06): : 468 - 469
  • [32] Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells
    Chen, Bin
    Wang, Yuanzhong
    Kane, Susan E.
    Chen, Shiuan
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2008, 41 (5-6) : 367 - 377
  • [33] PKIB Inhibits Autophagy to Regulate Tamoxifen Resistance in Breast Cancer with Estrogen Receptor-Positive Status
    Sun, Lu
    Zong, Beige
    Li, Fei
    Qiao, Yina
    Jin, Ting
    Wang, Yihua
    Zhang, Yingzi
    Jin, Yudi
    Qu, Fanli
    Liu, Shengchun
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (11): : 6217 - 6229
  • [34] Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study
    Didembourg, Marie
    Reda, Sara
    Oldenburg, Johannes
    Ruehl, Heiko
    Douxfils, Jonathan
    Morimont, Laure
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 546 - 554
  • [35] Sensitization of estrogen receptor-positive breast cancer cells to tamoxifen by novel epi-oligomycin A
    Yastrebova, M. A.
    Omelchuk, O.
    Lysenkova, L.
    Mikhaevich, E.
    Scherbakov, A. M.
    Shchekotikhin, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
    Stella, Stefania
    Massimino, Michele
    Manzella, Livia
    Parrinello, Nunziatina Laura
    Vitale, Silvia Rita
    Martorana, Federica
    Vigneri, Paolo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [37] Pharmacogenomic prediction of breast cancer treatment outcome with adjuvant tamoxifen in postmenopausal women with estrogen receptor-positive breast cancer
    Pribylova, O.
    Petruzelka, L. B.
    Argalaczova, S.
    Konopasek, B.
    Drazdakova, J.
    Slanar, O.
    Slanar, O.
    Zima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Research review: Treatment of breast cancer with tamoxifen in older women with estrogen receptor-positive breast cancer: Motivational issues
    Resnick, B
    GERIATRIC NURSING, 2004, 25 (06) : 372 - 372
  • [39] Cytotoxicity of tamoxifen and its major metabolites in breast cancer cell lines.
    BachmannMoisson, N
    BarberiHeyob, M
    Merlin, JL
    Ledrich, ML
    Batt, AM
    Guillemin, F
    BULLETIN DU CANCER, 1996, 83 (10) : 809 - 815
  • [40] Citrus polymethoxyflavones degrade estrogen receptor-alpha (ERα) and combine with tamoxifen for the treatment of estrogen receptor-positive breast cancer
    Wang, Yiyu
    Sun, Meng
    He, Zhong
    Han, Ying
    Song, Yinhong
    Liang, Jianjia
    Wang, Huimin
    Qin, Ye
    Deng, Zhangshuang
    HELIYON, 2024, 10 (12)
12345